disopyramide and amrubicinol

disopyramide has been researched along with amrubicinol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, S; Hamada, A; Kishi, H; Matsunaga, Y; Mori, I; Okamoto, I; Saito, H; Sasaki, J; Semba, H; Uramoto, H; Yamagata, H	1

Trials

1 trial(s) available for disopyramide and amrubicinol

Article	Year
Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3 Topics: Aged; Anthracyclines; Antineoplastic Agents; Area Under Curve; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Disopyramide; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspnea; Female; Half-Life; Humans; Hypoxia; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Platelet Transfusion; Pneumonia; Steroids; Thrombocytopenia	2006

Article

Year

Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer.

Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:3

Topics: Aged; Anthracyclines; Antineoplastic Agents; Area Under Curve; Atrial Fibrillation; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Disopyramide; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspnea; Female; Half-Life; Humans; Hypoxia; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Platelet Transfusion; Pneumonia; Steroids; Thrombocytopenia

2006